about
Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy.Difficult clinical situations in the antiphospholipid syndrome.Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and SafetyHydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Renal involvement in autoimmune connective tissue diseases.Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study.Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.Current management of antiphospholipid syndrome-related thrombosis.Pregnancy and antiphospholipid syndrome.Perioperative management of antiphospholipid antibody-positive patients.A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern Taiwan.Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome
P2860
Q33394629-3EB560E2-23C2-4B9D-B061-65CD36B1A2BBQ33421814-6319FA6C-F781-4EA4-9CD3-03B7FCFA828EQ33692770-D3E096B7-9ADA-4135-A0B8-D517B125B3FAQ33747286-D2CA7F27-5676-460C-B4C7-5BAC4944998BQ34122035-5D0989B0-6310-4244-8B20-B1BC9CD4E537Q34654954-217B5CF5-8444-45FB-BB85-928056D99A6DQ35867162-101EB549-1CA6-4341-ACD5-2C0E46E9C980Q36879113-F06A9F53-9DDB-452C-9EE6-4784630259D0Q37141852-F666A8A9-B135-44B5-802B-32297E69DDC7Q37473270-E7B6D8C6-5E52-4226-8C78-042435E59EB8Q37642830-0A2ABFA1-9A64-438F-A95E-0E6059AD5755Q38070831-C6EC1518-1034-4D2E-9269-813FC8588413Q38211785-2A0AA2E1-16BD-4B93-9379-D8A62F6544F4Q43654143-CB4C7E98-D775-457B-AD68-3649648D3B2FQ50949676-843F6BF0-9568-4CD7-A8A7-E2AB439783CEQ58869486-4AEF0540-D775-48AC-847C-4D353262A8D5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New approaches for managing antiphospholipid syndrome.
@en
New approaches for managing antiphospholipid syndrome.
@nl
type
label
New approaches for managing antiphospholipid syndrome.
@en
New approaches for managing antiphospholipid syndrome.
@nl
prefLabel
New approaches for managing antiphospholipid syndrome.
@en
New approaches for managing antiphospholipid syndrome.
@nl
P2860
P356
P1476
New approaches for managing antiphospholipid syndrome.
@en
P2093
Doruk Erkan
P2860
P304
P356
10.1038/NCPRHEUM1017
P577
2009-03-01T00:00:00Z